OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models of Parkinson’s disease progression
Gloria E. Meredith, Patricia K. Sonsalla, Marie‐Françoise Chesselet
Acta Neuropathologica (2008) Vol. 115, Iss. 4, pp. 385-398
Open Access | Times Cited: 221

Showing 1-25 of 221 citing articles:

Pathological roles of MAPK signaling pathways in human diseases
Eun-Kyung Kim, Eui‐Ju Choi
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2010) Vol. 1802, Iss. 4, pp. 396-405
Open Access | Times Cited: 2232

Inflammation in neurodegenerative diseases
Sandra Amor, Fabìola Puentes, David Baker, et al.
Immunology (2010) Vol. 129, Iss. 2, pp. 154-169
Open Access | Times Cited: 1271

A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced Death
Kaoru Saijo, Beate Winner, Christian T. Carson, et al.
Cell (2009) Vol. 137, Iss. 1, pp. 47-59
Open Access | Times Cited: 887

A Guide to Neurotoxic Animal Models of Parkinson's Disease
Kim Tieu
Cold Spring Harbor Perspectives in Medicine (2011) Vol. 1, Iss. 1, pp. a009316-a009316
Open Access | Times Cited: 442

MPTP Mouse Models of Parkinson's Disease: An Update
Gloria E. Meredith, David J. Rademacher
Journal of Parkinson s Disease (2011) Vol. 1, Iss. 1, pp. 19-33
Open Access | Times Cited: 436

Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar, Madhu Babu Gajula Balija, Sebastian Kügler, et al.
The EMBO Journal (2009) Vol. 28, Iss. 20, pp. 3256-3268
Open Access | Times Cited: 436

Brain Photobiomodulation Therapy: a Narrative Review
Farzad Salehpour, Javad Mahmoudi, Farzin Kamari, et al.
Molecular Neurobiology (2018) Vol. 55, Iss. 8, pp. 6601-6636
Open Access | Times Cited: 382

Oxidative Stress in Neurodegenerative Diseases
Robert R. Crichton, Roberta J. Ward
(2013), pp. 75-109
Open Access | Times Cited: 357

Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease
Lauren E. Scott, Chris Orvig
Chemical Reviews (2009) Vol. 109, Iss. 10, pp. 4885-4910
Closed Access | Times Cited: 318

The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
Eleftheria K. Pissadaki, J. Paul Bolam
Frontiers in Computational Neuroscience (2013) Vol. 7
Open Access | Times Cited: 313

α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
Isabel Lastres‐Becker, Ayşe Ulusoy, Nadia G. Innamorato, et al.
Human Molecular Genetics (2012) Vol. 21, Iss. 14, pp. 3173-3192
Closed Access | Times Cited: 243

Subthalamo‐pallidal interactions underlying parkinsonian neuronal oscillations in the primate basal ganglia
Yoshihisa Tachibana, Hirokazu Iwamuro, Hitoshi Kita, et al.
European Journal of Neuroscience (2011) Vol. 34, Iss. 9, pp. 1470-1484
Closed Access | Times Cited: 234

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Irina Alecu, Steffany A. L. Bennett
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 200

Advancement in the modelling and therapeutics of Parkinson’s disease
Sachchida Nand, Payal Singh
Journal of Chemical Neuroanatomy (2020) Vol. 104, pp. 101752-101752
Closed Access | Times Cited: 165

A critical reappraisal of current staging of Lewy-related pathology in human brain
K. A. Jellinger
Acta Neuropathologica (2008) Vol. 116, Iss. 1, pp. 1-16
Closed Access | Times Cited: 217

A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
K. A. Jellinger
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2008) Vol. 1792, Iss. 7, pp. 730-740
Open Access | Times Cited: 217

Misfolded protein aggregates: Mechanisms, structures and potential for disease transmission
Inés Moreno‐González, Claudio Soto
Seminars in Cell and Developmental Biology (2011) Vol. 22, Iss. 5, pp. 482-487
Open Access | Times Cited: 212

Formation and development of Lewy pathology: a critical update
K. A. Jellinger
Journal of Neurology (2009) Vol. 256, Iss. S3, pp. 270-279
Closed Access | Times Cited: 185

The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
Lin W. Hung, Victor L. Villemagne, Lesley Cheng, et al.
The Journal of Experimental Medicine (2012) Vol. 209, Iss. 4, pp. 837-854
Open Access | Times Cited: 165

Drosophila melanogaster as a Model Organism of Brain Diseases
Astrid Jeibmann, Werner Paulus
International Journal of Molecular Sciences (2009) Vol. 10, Iss. 2, pp. 407-440
Open Access | Times Cited: 160

Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease
Fabiana Morroni, Andrea Tarozzi, Giulia Sita, et al.
NeuroToxicology (2013) Vol. 36, pp. 63-71
Closed Access | Times Cited: 156

Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
Gusheng Wu, Zihua Lu, Neil Kulkarni, et al.
Journal of Neuroscience Research (2012) Vol. 90, Iss. 10, pp. 1997-2008
Closed Access | Times Cited: 150

The role of neuroinflammation on the pathogenesis of Parkinson's disease
Young-Cheul Chung, Hyuk Wan Ko, Eugene Bok, et al.
BMB Reports (2010) Vol. 43, Iss. 4, pp. 225-232
Open Access | Times Cited: 144

Early synaptic dysfunction in Parkinson's disease: Insights from animal models
Tommaso Schirinzi, Graziella Madeo, Giuseppina Martella, et al.
Movement Disorders (2016) Vol. 31, Iss. 6, pp. 802-813
Closed Access | Times Cited: 143

Page 1 - Next Page

Scroll to top